clinical trial Archive — Page 6 of 16

April 25, 2024

Advance in the treatment of acute heart failure identified

A multicenter study led by Vanderbilt University Medical Center and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.

Illustration of clinicians and biostatisticians working collaboratively on research
April 16, 2024

Unsung Zeros: How biostatistics advances personalized health in the era of smart data

VUMC is acrawl with statistical design, bias detection and analysis that’s recognized with $532 million in federal and nonfederal research support.

February 29, 2024

Study targets nicotine craving in schizophrenia

Vanderbilt’s Heather Burrell Ward, MD, has received a five-year, $928,000 grant from the National Institute on Drug Abuse to test whether an externally applied magnetic field can reduce nicotine craving in people with schizophrenia.

February 22, 2024

NIH-funded trial to determine if immunomodulation can improve brain and cardiovascular dysfunction in Long COVID

Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.

February 20, 2024

System offers new option to treat mitral regurgitation

In a novel procedure, the Vanderbilt Heart & Vascular Institute (VHVI) successfully performed the first large-flange Innovalve transcatheter mitral valve replacement.

February 2, 2024

Novel device helps extend window of time to preserve hearts donated after cardiac death

In the first such procedure, Vanderbilt University Medical Center has transplanted a DCD (donation after cardiac death) heart using XVIVO Heart Assist Transport (XHAT), a novel cold organ perfusion device.